BlackRock Fund Advisors - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$5,955,000
+16.7%
556,567
+18.2%
0.00%0.0%
Q3 2016$5,102,000
+72.1%
471,055
+7.5%
0.00%0.0%
Q2 2016$2,965,000
+56.6%
438,016
+7.8%
0.00%
Q1 2016$1,893,000
-25.9%
406,268
+0.4%
0.00%
-100.0%
Q4 2015$2,553,000
-26.2%
404,544
+3.2%
0.00%0.0%
Q3 2015$3,460,000
-25.9%
391,825
-1.2%
0.00%0.0%
Q2 2015$4,667,000
-21.8%
396,517
-3.8%
0.00%0.0%
Q1 2015$5,965,000
+6.2%
412,243
+25.2%
0.00%0.0%
Q4 2014$5,617,000
+64.7%
329,254
+20.3%
0.00%0.0%
Q3 2014$3,410,000
-18.5%
273,698
-4.0%
0.00%0.0%
Q2 2014$4,183,000
-24.4%
285,109
+4.9%
0.00%
-50.0%
Q1 2014$5,532,000
+7.4%
271,721
+3.4%
0.00%0.0%
Q4 2013$5,149,000
-56.2%
262,713
+1.2%
0.00%
-50.0%
Q3 2013$11,760,000
+115.3%
259,622
+13.3%
0.00%
+100.0%
Q2 2013$5,462,000229,0930.00%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders